Literature DB >> 18458172

Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication.

Mary M McDermott1, Jack M Guralnik, Luigi Ferrucci, Lu Tian, Kiang Liu, Yihua Liao, David Green, Robert Sufit, Frederick Hoff, Takashi Nishida, Leena Sharma, William H Pearce, Joseph R Schneider, Michael H Criqui.   

Abstract

BACKGROUND: This study assessed functional performance, calf muscle characteristics, peripheral nerve function, and quality of life in asymptomatic persons with peripheral arterial disease (PAD). METHODS AND
RESULTS: PAD participants (n=465) had an ankle brachial index <0.90. Non-PAD participants (n=292) had an ankle brachial index of 0.90 to 1.30. PAD participants were categorized into leg symptom groups including intermittent claudication (n=215) and always asymptomatic (participants who never experienced exertional leg pain, even during the 6-minute walk; n=72). Calf muscle was measured with computed tomography. Analyses were adjusted for age, sex, race, ankle brachial index, comorbidities, and other confounders. Compared with participants with intermittent claudication, always asymptomatic PAD participants had smaller calf muscle area (4935 versus 5592 mm(2); P<0.001), higher calf muscle percent fat (16.10% versus 9.45%; P<0.001), poorer 6-minute walk performance (966 versus 1129 ft; P=0.0002), slower usual-paced walking speed (P=0.0019), slower fast-paced walking speed (P<0.001), and a poorer Short-Form 36 Physical Functioning score (P=0.016). Compared with an age-matched, sedentary, non-PAD cohort, always asymptomatic PAD participants had smaller calf muscle area (5061 versus 5895 mm(2); P=0.009), poorer 6-minute walk performance (1126 versus 1452 ft; P<0.001), and poorer Walking Impairment Questionnaire speed scores (40.87 versus 57.78; P=0.001).
CONCLUSIONS: Persons with PAD who never experience exertional leg symptoms have poorer functional performance, poorer quality of life, and more adverse calf muscle characteristics compared with persons with intermittent claudication and a sedentary, asymptomatic, age-matched group of non-PAD persons.

Entities:  

Mesh:

Year:  2008        PMID: 18458172      PMCID: PMC5077147          DOI: 10.1161/CIRCULATIONAHA.107.736108

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  28 in total

1.  Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning: the women's health and aging study.

Authors:  M M McDermott; L Fried; E Simonsick; S Ling; J M Guralnik
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

2.  Ethnic-specific prevalence of peripheral arterial disease in the United States.

Authors:  Matthew A Allison; Elena Ho; Julie O Denenberg; Robert D Langer; Anne B Newman; Richard R Fabsitz; Michael H Criqui
Journal:  Am J Prev Med       Date:  2007-04       Impact factor: 5.043

3.  Chronic conditions that lead to functional limitation in the elderly.

Authors:  C Boult; R L Kane; T A Louis; L Boult; D McCaffrey
Journal:  J Gerontol       Date:  1994-01

4.  Lower extremity nerve function in patients with lower extremity ischemia.

Authors:  Mary M McDermott; Robert Sufit; Takashi Nishida; Jack M Guralnik; Luigi Ferrucci; Lu Tian; Kiang Liu; Jin Tan; William H Pearce; Joseph R Schneider; Leena Sharma; Michael H Criqui
Journal:  Arch Intern Med       Date:  2006-10-09

5.  Peripheral arterial disease detection, awareness, and treatment in primary care.

Authors:  A T Hirsch; M H Criqui; D Treat-Jacobson; J G Regensteiner; M A Creager; J W Olin; S H Krook; D B Hunninghake; A J Comerota; M E Walsh; M M McDermott; W R Hiatt
Journal:  JAMA       Date:  2001-09-19       Impact factor: 56.272

6.  Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment.

Authors:  M M McDermott; P Greenland; K Liu; J M Guralnik; M H Criqui; N C Dolan; C Chan; L Celic; W H Pearce; J R Schneider; L Sharma; E Clark; D Gibson; G J Martin
Journal:  JAMA       Date:  2001-10-03       Impact factor: 56.272

7.  Subclavian artery stenosis: prevalence, risk factors, and association with cardiovascular diseases.

Authors:  Ramin Shadman; Michael H Criqui; Warner P Bundens; Arnost Fronek; Julie O Denenberg; Anthony C Gamst; Mary M McDermott
Journal:  J Am Coll Cardiol       Date:  2004-08-04       Impact factor: 24.094

8.  Prognostic value of functional performance for mortality in patients with peripheral artery disease.

Authors:  Mary M McDermott; Lu Tian; Kiang Liu; Jack M Guralnik; Luigi Ferrucci; Jin Tan; William H Pearce; Joseph R Schneider; Michael H Criqui
Journal:  J Am Coll Cardiol       Date:  2008-04-15       Impact factor: 24.094

9.  Allometry between length and cross-sectional dimensions of the femur and tibia in Homo sapiens sapiens.

Authors:  C B Ruff
Journal:  Am J Phys Anthropol       Date:  1984-12       Impact factor: 2.868

10.  Prevalence and significance of unrecognized lower extremity peripheral arterial disease in general medicine practice*.

Authors:  M M McDermott; D R Kerwin; K Liu; G J Martin; E O'Brien; H Kaplan; P Greenland
Journal:  J Gen Intern Med       Date:  2001-06       Impact factor: 5.128

View more
  46 in total

Review 1.  Peripheral arterial disease and chronic heart failure: a dangerous mix.

Authors:  Sally C Inglis; Adriana Hermis; Sajad Shehab; Phillip J Newton; Sara Lal; Patricia M Davidson
Journal:  Heart Fail Rev       Date:  2013-07       Impact factor: 4.214

2.  Peripheral artery disease, calf skeletal muscle mitochondrial DNA copy number, and functional performance.

Authors:  Mary M McDermott; Charlotte A Peterson; Robert Sufit; Luigi Ferrucci; Jack M Guralnik; Melina R Kibbe; Tamar S Polonsky; Lu Tian; Michael H Criqui; Lihui Zhao; James H Stein; Lingyu Li; Christiaan Leeuwenburgh
Journal:  Vasc Med       Date:  2018-05-08       Impact factor: 3.239

Review 3.  Peripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosis.

Authors:  Joe F Lau; Mitchell D Weinberg; Jeffrey W Olin
Journal:  Nat Rev Cardiol       Date:  2011-05-31       Impact factor: 32.419

4.  Peripheral artery disease: current insight into the disease and its diagnosis and management.

Authors:  Jeffrey W Olin; Brett A Sealove
Journal:  Mayo Clin Proc       Date:  2010-07       Impact factor: 7.616

5.  Relationship of femoral artery ultrasound measures of atherosclerosis with chronic kidney disease.

Authors:  Simon Hsu; Dena E Rifkin; Michael H Criqui; Natalie C Suder; Pranav Garimella; Charles Ginsberg; Antoinette M Marasco; Belinda J McQuaide; Emma J Barinas-Mitchell; Matthew A Allison; Christina L Wassel; Joachim H Ix
Journal:  J Vasc Surg       Date:  2017-12-22       Impact factor: 4.268

Review 6.  Exercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefits.

Authors:  Naomi M Hamburg; Gary J Balady
Journal:  Circulation       Date:  2011-01-04       Impact factor: 29.690

Review 7.  Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia.

Authors:  Mary McGrae McDermott
Journal:  Circ Res       Date:  2015-04-24       Impact factor: 17.367

Review 8.  Functional impairment in peripheral artery disease and how to improve it in 2013.

Authors:  Mary McGrae McDermott
Journal:  Curr Cardiol Rep       Date:  2013-04       Impact factor: 2.931

Review 9.  Preventing and treating foot complications associated with diabetes mellitus.

Authors:  Frank L Bowling; S Tawqeer Rashid; Andrew J M Boulton
Journal:  Nat Rev Endocrinol       Date:  2015-08-18       Impact factor: 43.330

10.  Ankle-brachial index predicts change over time in functional status in the San Diego Population Study.

Authors:  Christina L Wassel; Matthew A Allison; Joachim H Ix; Dena E Rifkin; Nketi I Forbang; Julie O Denenberg; Michael H Criqui
Journal:  J Vasc Surg       Date:  2016-04-29       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.